| USD millions | FY2025 | TTM |
|---|---|---|
| Revenue | 0.0 | 0.0 |
| Cost of revenue | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 |
| Research & development | 0.0 | — |
| Selling, general & administrative | 177.8 | — |
| Selling & marketing | 0.0 | — |
| Operating expenses | 177.8 | 365.1 |
| Operating income | (177.8) | (365.1) |
| Interest expense | 0.0 | (5.4) |
| Interest income | 0.0 | — |
| Other income / expense | (308.6) | — |
| Pre-tax income | (486.4) | (694.5) |
| Income tax | 0.0 | 0.0 |
| Net income | (486.4) | (694.5) |
| Discontinued operations | 0.0 | — |
| Other net income adjustments | 0.0 | — |
| EPS, basic (per share) | (1.13) | (1.32) |
| EPS, diluted (per share) | (1.13) | (1.32) |
| EBITDA | (486.4) | (387.5) |
| Depreciation & amortization | 0.0 | — |
| Weighted average shares (shares) | 467,963,408 | — |
| Weighted average diluted shares (shares) | 467,963,408 | — |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-06-30 and uses four consecutive reported quarters.